Wong Nicole R, Klomhaus Alexandra, Adams David J, Schneider Benjamin N, Mehta Sunil, DiStefano Charlotte, Wilson Rujuta B, Martinez-Agosto Julian A, Jeste Shafali S, Besterman Aaron D
Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD.
Department of General Internal Medicine and Health Services Research, University of California, Los Angeles, CA.
Genet Med. 2025 Jan;27(1):101252. doi: 10.1016/j.gim.2024.101252. Epub 2024 Oct 11.
This study aimed to identify phenotypic factors associated with genetic diagnoses in patients with neurodevelopmental disorders and generate a decision tree to assist clinicians in identifying patients most likely to receive a positive result on genetic testing.
We retrospectively reviewed the charts of 316 patients evaluated in a neurodevelopmental clinic between 2014 and 2019. Patients were categorized based on genetic test results. Analyses were performed to identify variables that discriminate between patients with and without a genetic diagnosis.
Patients with a genetic diagnosis were more likely to be female and have a history of motor delay, hypotonia, congenital heart disease, and early intervention. Classification and regression tree analysis revealed that 75% of patients with motor delay had a genetic diagnosis. In patients without motor delay, hypotonia, age of walking, and age at initial evaluation were important indicators of a genetic diagnosis.
Our findings suggest that motor delay and hypotonia are associated with genetic diagnoses in children with neurodevelopmental disorders. The decision tree highlights patient subsets at greater risk and suggests possible phenotypic screens. Future studies could develop validated decision trees based on phenotypic data to assist clinicians in stratifying patients for genetic testing.
本研究旨在确定神经发育障碍患者中与基因诊断相关的表型因素,并生成一个决策树,以帮助临床医生识别最有可能在基因检测中获得阳性结果的患者。
我们回顾性分析了2014年至2019年间在一家神经发育诊所接受评估的316例患者的病历。根据基因检测结果对患者进行分类。进行分析以确定能够区分有基因诊断和无基因诊断患者的变量。
有基因诊断的患者更可能为女性,并有运动发育迟缓、肌张力低下、先天性心脏病和早期干预史。分类与回归树分析显示,75%的运动发育迟缓患者有基因诊断。在无运动发育迟缓的患者中,肌张力低下、开始走路的年龄和初次评估时的年龄是基因诊断的重要指标。
我们的研究结果表明,运动发育迟缓及肌张力低下与神经发育障碍儿童的基因诊断相关。该决策树突出了风险较高的患者亚组,并提示了可能的表型筛查。未来的研究可以基于表型数据开发经过验证的决策树,以帮助临床医生对患者进行基因检测分层。